UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000043222
Receipt No. R000045884
Scientific Title Pulmonary hypertension and Telemedicine -a validity trial
Date of disclosure of the study information 2021/03/01
Last modified on 2021/02/02 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Remote medicine by videophone in patients with pulmonary hypertension
Acronym PH-TV trial
Scientific Title Pulmonary hypertension and Telemedicine -a validity trial
Scientific Title:Acronym PH-TV trial
Region
Japan

Condition
Condition Pulmonary hypertension
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess efficacy of telemedicine on QOL in patients with pulmonary hypertension
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Health related quality of life assessed by SF-36 at baseline,2 months and 3 months after inclusion
Key secondary outcomes Change in vital signs
Clinical events (unexpected hospitalization and death) during study period

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Use of telemedicine system including videophone,sphygmomanometer, weight scale, pulse oxmeter, ECG monitor
3 months
To See a patient by videophone (once per month,from day 1 to 30 and from day 61 to 90)
To See a patient at outpatient clinic (once per month,from day 31 to 60)
Interventions/Control_2 control
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with pulmonary hypertension treated in our hospital (age>=18 years old)
Key exclusion criteria Patients with permanent pacemaker
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Takeshi
Middle name
Last name Ogo
Organization National Cerebral Cardiovascular Center
Division name Cardiovascular Department
Zip code 564-8565
Address 6-1, Kishibe Shin-machi, Suita city, Osaka, Japan
TEL 06-6170-1070
Email tak@ncvc.go.jp

Public contact
Name of contact person
1st name Tatsuo
Middle name
Last name Aoki
Organization National Cerebral Cardiovascular Center
Division name Cardiovascular Department
Zip code 564-8565
Address 6-1, Kishibe Shin-machi, Suita city, Osaka, Japan
TEL 06-6170-1070
Homepage URL
Email aoki.tatsuo@ncvc.go.jp

Sponsor
Institute National Cerebral Cardiovascular Center
Institute
Department

Funding Source
Organization SECOM MEDICAL SYSTEM CO.,LTD.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization REC
Address 6-1, Kishibe Shin-machi, Suita city, Osaka, Japan
Tel 06-6170-1070
Email rec-office-ac@ncvc.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 03 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 08 Month 20 Day
Date of IRB
2020 Year 08 Month 20 Day
Anticipated trial start date
2020 Year 08 Month 21 Day
Last follow-up date
2024 Year 04 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 02 Month 02 Day
Last modified on
2021 Year 02 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045884